100 million euro fund for biotechnology launched in France

Early stage biotechnology companies will gain access to a major source of funding in France, with €50 million being set aside by both the French state bank (BpiFrance) and pharmaceutical company Sanofi. If suitable other partners engage with the fund, up to €250 million could eventually become available.

In a related announcement, France is also set to launch a new process for market access of medicines, reducing the time frame from 275 days to 180 by 2022.

Read this story on the Reuters news page.

Tagged with

Published 10. July 2018 in News, News France